Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.3115
-0.0105 (-3.26%)
At close: Aug 1, 2025, 4:00 PM
0.3100
-0.0015 (-0.48%)
After-hours: Aug 1, 2025, 7:31 PM EDT

Carisma Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts that cover Carisma Therapeutics stock have a consensus rating of "Hold" and an average price target of $0.90, which forecasts a 188.92% increase in the stock price over the next year. The lowest target is $0.70 and the highest is $1.00.

Price Target: $0.90 (+188.92%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$0.70$0.90$1.00$1.00
Change+124.72%+188.92%+221.03%+221.03%
* Price targets were last updated on Apr 1, 2025.

Analyst Ratings

The average analyst rating for Carisma Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111111
Buy000000
Hold444444
Sell000000
Strong Sell000000
Total555555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$12$1
Strong BuyMaintains$12$1+221.03%Apr 1, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$12
Strong BuyMaintains$12+3,752.33%Jan 17, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$12
Strong BuyMaintains$12+3,752.33%Jan 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aDec 16, 2024
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$12
Strong BuyMaintains$12+3,752.33%Dec 12, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
17.85M
from 19.63M
Decreased by -9.08%
Revenue Next Year
n/a
from 17.85M
EPS This Year
-0.66
from -1.46
EPS Next Year
-0.67
from -0.66
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
--9.83M14.92M19.63M17.85M--
Revenue Growth
---51.71%31.59%-9.08%--
EPS
-26.66-37.62-28.77-2.59-1.46-0.66-0.67-0.56
EPS Growth
--------
Forward PE
--------
No. Analysts
-----433
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High21.0Mn/an/a
Avg17.9Mn/an/a
Low14.7Mn/an/a

Revenue Growth

Revenue Growth20252026202720282029
High
7.0%
--
Avg
-9.1%
--
Low
-25.1%
--

EPS Forecast

EPS20252026202720282029
High-0.43-0.69-0.58
Avg-0.66-0.67-0.56
Low-0.86-0.65-0.54

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.